CClinicalTrials.gg
CompletedNCT01951807Updated Nov 17, 2017

Psychological Interventions for Gynecologic Cancer

An interventional study of Psychotherapy in Gynecologic Cancer, sponsored by Rutgers, The State University of New Jersey. Completed at 9 sites in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-17.

Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
375
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Subjects that have received medical treatment for ovarian cancer can be both physically and emotionally demanding for patients. The purpose of this study is to determine whether two common pyschological interventions (Communication Skills Intervention and Supportive Counseling) may improve the well-being of ovarian cancer patients compared to usual care.

Read the detailed description

Very little is known in the psycho-oncology literature about why psychological interventions are effective or for how long these interventions exert an impact. Given many cancer patients experience recurrence and/or progression, it is important to know whether our relatively brief interventions facilitate how patients cope with this most-feared medical event. From a theoretical perspective, the study will advance our understanding of the mechanisms for change for two common treatment approaches, supportive and cognitive behavioral therapies.

Subjects will be enrolled and upon completion of a baseline survey, randomized to into one of three arms - Communication Skills Intervention, Supportive Counseling, and Usual Care. Subjects will complete surveys during the course of the interventions.

02

Conditions studied

  • Gynecologic Cancer

Keywords

  • Psychosocial Effects of Cancer and Treatment
  • Coping
03

In context

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Newly diagnosed with any stage of primary ovarian cancer, primary peritoneal cancer, or primary fallopian tube cancer in the past 6 months
  • Newly diagnosed with High Grade Stage 2, any grade Stage 3 or higher endometrial cancer in the past 6 months
  • Newly diagnosed with Stage 2 or higher cervical cancer withing the past 6 months
  • Newly diagnosed with any stage of Uterine cancer (both sarcoma and carcinosarcoma) in the past 6 months
  • At the time of recruitment, the patient is on active treatment defined as either currently receiving chemotherapy or radiation or less than 6 months post-cancer surgery
  • At the time of recruitment, a Karnofsky Performance Status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1
  • English speaking
  • Lives within a two-hour commuting distance from the recruitment site
  • No hearing impairment
  • Has signed consent within 6 months of diagnosis date
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
375 participants (actual)

Study arms

  • Experimental
    Coping & Communication Skills

    The CCI intervention focuses on bolstering stress management and problem solving abilities, identifying and expressing support needs constructively, facilitating the ability to cope with unchangeable issues, cognitive restructuring, and dealing effectively with body image and sexuality issues over seven weekly 60 minute sessions.

    Behavioral: Psychotherapy

  • Experimental
    Supportive Counseling (SC)

    The SC intervention incorporates a supportive, non-directive counseling approach in seven weekly 60 minute sessions

    Behavioral: Psychotherapy

  • No intervention
    Usual Care (UC)

    Patients receive standard psychological and emotional care (usual care \[UC\]) (i.e., social work consultations and referral to a psychiatrist or psychologist, if requested or deemed necessary by the attending physician).

Interventions

  • BehavioralPsychotherapy
06

What researchers measure

Primary outcomes

  1. Do the two psychological interventions, CCI and SC, result in greater improvements in global psychological adaptation

    Global Psychological distress: Depressive symptoms - The BDI is a 21-item scale which has been widely used in studies incorporating cognitive-behavioral interventions.The MHI-18 has subscales for Psychological Distress and Well-being.

    Time frame: 7 years

  2. Do the two psychological interventions, CCI and SC, result in greater improvements in cancer-specific psychological adaptation

    Cancer-Specific Distress: Traumatic Stress. The Impact of Events Scale (IES) is a 15-item self-report measure focusing on intrusive and avoidant ideation related to gynecologic cancer and its treatment. Using a 4-point Likert scale, participants rated how true each statement has been for them during the past week (scale range = 0-75). Fear of Recurrence/Progression. The Concerns about Recurrence Scale (CARS) is a 26 item assessment of the nature of women's fears about cancer recurrence.

    Time frame: 7 years

  3. Do the two psychological interventions, CCI and SC, result in greater improvements in quality of life

    Quality of Life-General. The Functional Assessment of Cancer Therapy - General (FACT-G) is a widely used measure of QOL. The FACT-G is comprised of 27 questions that assess well-being in four domains: physical, functional, social/family, and emotional. Spiritual well-being. The FACIT Spiritual well-being scale assesses a sense of meaning in life, harmony, peacefulness, sense of strength, and comfort from one's faith. The 12 item scale has two factors: Meaning/Peace and Faith.

    Time frame: 7 years

07

Study locations

9 sites
  • Cooper Health System
    Camden, New Jersey 08103, United States
  • Cancer Institute of New Jersey at Hamilton
    Hamilton, New Jersey 08690, United States
  • Morristown Medical Center
    Morristown, New Jersey 07960, United States
  • Rutgers Cancer Institute of New Jersey
    New Brunswick, New Jersey 08903, United States
  • Memorial Sloan Kettering Cancer Center
    New York, New York 10022, United States
  • Jefferson University School of Medicine
    Philadelphia, Pennsylvania 19107, United States
  • Thomas Jefferson University
    Philadelphia, Pennsylvania 19107, United States
  • Fox Chase Cancer Center
    Philadelphia, Pennsylvania 19111, United States
  • University of Pennsylvania Health System
    Philadelphia, Pennsylvania 19111, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01951807
Lead sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI), Rutgers Cancer Institute of New Jersey
Responsible party
Sponsor
First posted
Sep 27, 2013
Start date
Jun 2010
Primary completion
Jul 19, 2017
Completion
Jul 19, 2017
Last update
Nov 17, 2017

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion